Teleflex (NYSE:TFX) Issues Quarterly Earnings Results

by · The Cerbat Gem

Teleflex (NYSE:TFX – Get Free Report) posted its earnings results on Thursday. The medical technology company reported $3.67 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.38 by $0.29, Zacks reports. The company had revenue of $892.90 million during the quarter, compared to analysts’ expectations of $892.79 million. Teleflex had a return on equity of 15.08% and a net margin of 6.31%.The firm’s quarterly revenue was up 19.4% compared to the same quarter last year. During the same quarter last year, the firm earned $3.49 earnings per share. Teleflex updated its FY 2025 guidance to 14.000-14.200 EPS.

Teleflex Stock Down 13.0%

NYSE:TFX traded down $16.25 during midday trading on Thursday, reaching $108.50. The company had a trading volume of 2,953,542 shares, compared to its average volume of 743,018. The firm has a market capitalization of $4.79 billion, a price-to-earnings ratio of 25.53, a PEG ratio of 1.79 and a beta of 1.05. The stock’s fifty day simple moving average is $126.01 and its 200-day simple moving average is $123.27. Teleflex has a 12-month low of $102.58 and a 12-month high of $203.33. The company has a current ratio of 2.41, a quick ratio of 1.44 and a debt-to-equity ratio of 0.42.

Teleflex Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, December 15th. Investors of record on Friday, November 14th will be issued a $0.34 dividend. The ex-dividend date is Friday, November 14th. This represents a $1.36 dividend on an annualized basis and a yield of 1.3%. Teleflex’s dividend payout ratio (DPR) is 32.00%.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on the company. Zacks Research cut Teleflex from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, September 30th. Royal Bank Of Canada raised their target price on Teleflex from $130.00 to $135.00 and gave the stock a “sector perform” rating in a research note on Friday, August 1st. Weiss Ratings restated a “sell (d+)” rating on shares of Teleflex in a research report on Wednesday, October 8th. Mizuho raised their price target on Teleflex from $130.00 to $135.00 and gave the stock a “neutral” rating in a research report on Friday, August 1st. Finally, Wells Fargo & Company lowered their price target on Teleflex from $137.00 to $131.00 and set an “equal weight” rating for the company in a research report on Friday, August 1st. One analyst has rated the stock with a Buy rating, nine have given a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat, the company currently has an average rating of “Reduce” and a consensus target price of $141.57.

Get Our Latest Research Report on Teleflex

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. AQR Capital Management LLC boosted its holdings in Teleflex by 39.9% in the second quarter. AQR Capital Management LLC now owns 409,320 shares of the medical technology company’s stock valued at $48,447,000 after purchasing an additional 116,797 shares during the period. Ameriprise Financial Inc. raised its stake in Teleflex by 177.9% in the second quarter. Ameriprise Financial Inc. now owns 305,519 shares of the medical technology company’s stock valued at $36,161,000 after buying an additional 195,581 shares in the last quarter. The Manufacturers Life Insurance Company raised its stake in Teleflex by 146.0% in the second quarter. The Manufacturers Life Insurance Company now owns 231,624 shares of the medical technology company’s stock valued at $27,415,000 after buying an additional 137,470 shares in the last quarter. Balyasny Asset Management L.P. raised its stake in Teleflex by 12.5% in the second quarter. Balyasny Asset Management L.P. now owns 216,656 shares of the medical technology company’s stock valued at $25,643,000 after buying an additional 24,044 shares in the last quarter. Finally, Man Group plc raised its stake in Teleflex by 16.5% in the second quarter. Man Group plc now owns 186,512 shares of the medical technology company’s stock valued at $22,076,000 after buying an additional 26,470 shares in the last quarter. 95.62% of the stock is currently owned by hedge funds and other institutional investors.

Teleflex Company Profile

(Get Free Report)

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.

Featured Stories